Share
 
Title
Code
Session Type
Venue
Date Time
Co-Facilitators:
Level:
Target Audience:
Seating limit:

Multiple studies have suggested that the use of tenofovir-emtricitabine can decrease HIV incidence, but only recently have local public health authorities implemented PrEP in clinical sites as part of an integrated HIV prevention package. This workshop shares best practices in PrEP provision from around the world, including case studies.

14:30
WEWS0801
Welcome and introduction
Helen Rees, University of Witwatersrand, South Africa
Kenneth Mayer, Fenway Health, United States
14:40
WEWS0802
PrEP rollout in Kenya
Michael Kiragu, LVCT Health, Kenya
Slides
14:50
WEWS0803
Strategic approaches of the South African government as it considers PrEP implementation
Yogan Pillay, National Department of Health, South Africa
15:00
WEWS0804
PrEP rollout in France
Jean-Michel Molina, University of Paris Diderot, France
Slides
15:10
WEWS0805
Expanded implementation of PrEP across Australia
Iryna Zablotska, University of New South Wales (UNSW), Australia
Slides
15:20
WEWS0806
Interactive discussion
15:30
WEWS0807
Conclusion and closing remarks
Helen Rees, University of Witwatersrand, South Africa
Kenneth Mayer, Fenway Health, United States